All In MedTech

FDA Clearance Tracker · P160017-S076

MiniMed 770G System

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Aug 31, 2020 (this decision)Source: openFDAMethods & limitations

PMA supplementBreakthrough

Decided

Aug 31, 2020

Approved

Time to decision

304 days

Received Nov 1, 2019. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Panel Track

Device class

Class III

The decision

FDA number
P160017-S076
Device name
MiniMed 770G System
Applicant location
Northridge, CA
Received
Nov 1, 2019
Decided
Aug 31, 2020
Decision
Approved
Supplement type
Panel Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P160017

Device type

Device class
Class III

Every decision under product code OZP

FDA's approval statement

As written in FDA's record.

Approval of the MiniMed 770G System to expand the indications for use to use users down to 2 years old and to update the pump communication protocol to Bluetooth Low Energy (BLE).

Source documents

Other decisions for Medtronic Minimed, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.